England rolls out life-extending drug for breast cancer patients

The NHS in England approves Enhertu, a drug providing an average of seven extra months of survival.

Published 2h1 sourceImportant

≈ 21sSpeed

The fact

Already available in Scotland for two years, this treatment targets advanced or metastatic forms.

This decision expands access to an innovative therapy for thousands of women.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 17, 2026